期刊文献+

不同粒径多西他赛固体脂质纳米粒制剂及其细胞毒活性 被引量:3

Pharmacy characters and cytotoxic activity of docetaxel-loaded solid lipid nanoparticles with different sizes
下载PDF
导出
摘要 目的制备不同粒径的多西他赛(docetaxel,DTX)固体脂质纳米粒,考察多西他赛固体脂质纳米粒理化性质,研究粒径对体外释放行为以及细胞毒作用的影响。方法通过热熔超声法制备不同粒径多西他赛固体脂质纳米粒,观察纳米粒形态,测定其包封率、粒径、Zeta电位。考察粒径因素对固体脂质纳米粒体外释放行为、体外细胞毒性的影响。结果制备的纳米粒均为球形及类球形,3种粒径的多西他赛固体脂质纳米粒平均粒径分别为(83.7±8.4)、(162.7±11.9)、(232.1±26.4)nm;Zeta电位分别为-24.19、-23.67、-23.19 mV;包封率分别为98.03%、97.84%、97.92%。60 h粒径分别为83、16、232 nm的多西他赛固体脂质纳米粒在释放介质中分别累计释放86.34%、76.98%、67.14%。3种不同粒径多西他赛固体脂质纳米粒(DTX-SLN-83,DTX-SLN-162,DTX-SLN-232),多西他赛原料药(DTX solutions)以及空白SLN溶液与多西他赛的混合溶液(physi-calm ixture)对MCF-7细胞作用24 h的IC50值分别为3.36、6.20、9.74、13.15、12.92 mg.L-1;48 h的IC50值分别为0.93、2.01、4.35、9.48、9.21 mg.L-1;72 h的IC50值分别为0.30、0.91、1.67、7.36、7.82 mg.L-1。随着多西他赛固体脂质纳米粒粒径的减小,其肿瘤细胞杀伤力逐渐增强。结论热熔超声法可用于制备不同粒径多西他赛固体脂质纳米粒。降低固体脂质纳米粒粒径有利于药物更完全地释放,同时增强其对肿瘤细胞的杀伤能力。 Objective To prepare different sizes of docetaxel-loaded solid lipid nanoparticles,study their physico-chemical properties and investigate the effect of paricle size on drug release in vitro and cytotoxic effect.Methods The different sizes of docetaxel-loaded solid lipid nanoparticles were prepared by melt-emulsification-ultrasound method.The shape of SLN,entrapment efficiencies,particle size and Zeta potential were evaluated.The drug release and cytotoxicity in vitro were investigated among different sizes of docetaxel-loaded solid lipid nanoparticles.Results The results showed that the solid lipid nanoparticles were sphere and sphere-like.The particle sizes of the three kinds of docetaxel-loaded solid lipid nanoparticles were(83.7±8.4)nm,(162.7±11.9)nm,(232.1±26.4)nm,respectively.Zeta potential,entrapment efficiency and the cumulative release during 60 h of the DTX-SLN-83,DTX-SLN-162 and DTX-SLN-232 seperately were-24.19,-23.67,-23.19 mV;98.03%,97.84%,97.92%;86.34%,76.98%,67.14%,ND.After incubation for 24 h,the IC50 values of DTX-SLN-80,DTX-SLN-160,DTX-SLN-230,DTX solution and physical mixture were 3.36,6.20,9.74,13.15,12.92 mg·L-1;after incubation for 48 h,the IC50 values were 0.93,2.01,4.35,9.48,9.21 mg·L-1,after incubation for 72 h,the IC50 values were 0.30,0.91,1.67,7.36,7.82 mg·L-1.The results showd that the reduction of particle size could improve inhibitory action on tumor cells.Conclusions Using the melt-enmulsification-ultrasound method,the preparation of docetaxel-loaded solid lipid nanoparticles is highly feasible.The particle size of SLN has a significant influence on the drug release and cytotoxicity in vitro.There was a higher efficiency in killing MCF-7 cells in vitro and a faster drug release of docetaxel-loaded solid lipid nanoparticles with a decrease of particle size.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2010年第12期940-945,共6页 Journal of Shenyang Pharmaceutical University
关键词 固体脂质纳米粒 多西他赛 粒径 体外释放 体外细胞毒作用 solid lipid nanoparticle docetaxel particle size in vitro release in vitro cytotoxic effect
  • 相关文献

参考文献10

  • 1BISSERY M C, GUENARD D, FUERITTE VOEGELEIN F. Experimental antitumor activity of taxotere, ataxol analogue[J]. Cancer Res, 1991,51:4845.
  • 2RISCHIN D,BOYER M, SMITH J,et al. A phase I trial of docetaxel and gemcitabine in patients with advanced cancer [ J ]. Ann Oncol, 2000, 11 ( 4 ) : 421 - 426.
  • 3CHANG A Y, RUBINS J, ASBURY R, et al. Weekly paclitaxel in advanced non-small cell lung cancer, Semi[J]. Oncol,2001,28 : 10 - 13.
  • 4ISHITOBI M, SHIN E, KIKKAWA N, Metastatic breast cancer with resistance to both anthracycline and docetaxel successfully treated with weekly paclitaxel [J]. Int J Clin Oncol,2001,6 :55 -58.
  • 5BOUVIER E,THIROT S ,SCHMIDT F,et al. First enzyrnatically activated Taxotere prodrugs designed for ADEPT and PMT, Bioorg [ J ]. Med Chem, 2004,12: 969 - 977.
  • 6VAN ZUYLEN L, VERWEIJ J, Sparreboom A. Role of formulation vehicles in taxane pharmacology, Invest [ J]. New Drugs,2001,19 : 125 - 141.
  • 7KRISTL J, KOKOL D, SMID K J. Solid lipid nanoparticles formation, characterization and possibilities of drug delivry [ J ]. Farm Vesdn, 1997,48 ( 1 - 2 ) : 123.
  • 8DESAI M P, LABHASETWAR V, WALTER E. The-mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent [ J ]. Pharm Res 1997,14:1568 - 1573.
  • 9RFAMAN J, OBERLE V, ZUHORN I S. Size-dependent internalization of particle via the pathways of clathrin-and caveolae-mediated endocytosis[J]. Biochem J,2004,377 : 159 - 169.
  • 10秦绿叶,刘爽,汪沉然,王均辉,岳鑫,于常海.巨胞饮的机制及功能的研究进展[J].生理科学进展,2006,37(1):41-44. 被引量:9

二级参考文献10

  • 1Swanson JA, Watts C. Macropinocytosis. Trends Cell Biol,1995, 5 : 424 -428.
  • 2Riezman H, Woodman PG, Meer G, et al. Molecular mechanisms of endocytosis. Cell, 1997, 91 : 731 - 738.
  • 3Cardelli J. Phagocytosis and macropinocytosis in Dictyostelium. phosphoinositide-based processes, biochemically distinct. Traffic, 2001, 2 : 311 -320.
  • 4Lefkir Y, Malbouyres M, Gotthardt D, et al. Involvement of the AP-1 adaptor complex in early steps of phagocytosis and macropinocytosis. Mol Biol Cell, 2004, 15 : 861 -869.
  • 5Amyere M, Mettlen M, Van Der SP, et al. Origin, originality, functions, subversions and molecular signalling of macropinocytosis. Int J Med Microbiol, 2002, 291 : 487 -494.
  • 6Burridge K, Wennerberg K. Rho and Rac take center stage.Cell, 2004, 116 : 167 -179.
  • 7Dharmawardhane S, Schurmann A, Sells MA, et al. Regulation of macropinocytosis by p21-acfivated kinase-1. Mol Biol Cell, 2000, 11 : 3341 -3352.
  • 8Anton IM, Saville SP, Byme MJ, et al. WIP participates in actin reorganization and ruffle formation induced by PDGF. J Cell Sci, 2003, 116 : 2443 -2451.
  • 9Sun P, Yamamoto H, Suetsugu S, et al. Small GTPase Rah/Rab34 is associated with membrane rattles and macropinosomes and promotes macropinosome formation. J Biol Chem, 2003, 278 : 4063-4071.
  • 10Miki H, Yamaguchi H, Suetsugu S, et al. IRSp53 is an essential intermediate between Rac and WAVE in the regulation of membrane ruffling. Nature, 2000, 408 : 732 -735.

共引文献8

同被引文献27

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部